JP2019519470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019519470A5 JP2019519470A5 JP2018552798A JP2018552798A JP2019519470A5 JP 2019519470 A5 JP2019519470 A5 JP 2019519470A5 JP 2018552798 A JP2018552798 A JP 2018552798A JP 2018552798 A JP2018552798 A JP 2018552798A JP 2019519470 A5 JP2019519470 A5 JP 2019519470A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- composition according
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004965 antibodies Human genes 0.000 claims description 26
- 108090001123 antibodies Proteins 0.000 claims description 26
- 239000000427 antigen Substances 0.000 claims description 20
- 102000038129 antigens Human genes 0.000 claims description 20
- 108091007172 antigens Proteins 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 12
- 102000004889 Interleukin-6 Human genes 0.000 claims description 11
- 108090001005 Interleukin-6 Proteins 0.000 claims description 11
- 230000004043 responsiveness Effects 0.000 claims description 8
- 102000010781 Interleukin-6 Receptors Human genes 0.000 claims description 7
- 108010038501 Interleukin-6 Receptors Proteins 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 4
- 201000001069 multicentric Castleman disease Diseases 0.000 claims description 4
- 210000002966 Serum Anatomy 0.000 claims description 2
- 230000003001 depressive Effects 0.000 claims description 2
- 230000036651 mood Effects 0.000 claims description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662319558P | 2016-04-07 | 2016-04-07 | |
| US62/319,558 | 2016-04-07 | ||
| PCT/US2017/026395 WO2017177032A2 (en) | 2016-04-07 | 2017-04-06 | Treatment of depression using agents that block binding of il-6 to il-6 receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019519470A JP2019519470A (ja) | 2019-07-11 |
| JP2019519470A5 true JP2019519470A5 (de) | 2020-05-07 |
Family
ID=59998986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018552798A Pending JP2019519470A (ja) | 2016-04-07 | 2017-04-06 | Ｉｌ−６受容体へのｉｌ−６の結合を遮断する薬剤を用いたうつ病の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170291942A1 (de) |
| EP (1) | EP3440108A4 (de) |
| JP (1) | JP2019519470A (de) |
| AU (1) | AU2017248280A1 (de) |
| CA (1) | CA3019828A1 (de) |
| MA (1) | MA44631A (de) |
| WO (1) | WO2017177032A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190345245A1 (en) * | 2018-05-11 | 2019-11-14 | Janssen Biotech, Inc. | Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7291721B2 (en) * | 2001-11-14 | 2007-11-06 | Centocor, Inc. | Anti-IL-6 antibodies, compositions, methods and uses |
| PE20061324A1 (es) * | 2005-04-29 | 2007-01-15 | Centocor Inc | Anticuerpos anti-il-6, composiciones, metodos y usos |
| BRPI1007005A2 (pt) * | 2009-01-29 | 2016-03-22 | Medimmune Llc | anticorpo isolado , ácido nucleico isolado n vetor, célula isolada , linhagem de célula isolada , composição farmacêutica, e, uso de um anticorpo anti-il-6 |
| JP6347477B2 (ja) * | 2013-12-27 | 2018-06-27 | 国立大学法人千葉大学 | 関節リウマチ患者に対する抗ｉｌ−６受容体抗体治療の有効性予測方法 |
-
2017
- 2017-04-06 EP EP17779843.6A patent/EP3440108A4/de active Pending
- 2017-04-06 MA MA044631A patent/MA44631A/fr unknown
- 2017-04-06 JP JP2018552798A patent/JP2019519470A/ja active Pending
- 2017-04-06 US US15/480,924 patent/US20170291942A1/en not_active Abandoned
- 2017-04-06 AU AU2017248280A patent/AU2017248280A1/en not_active Abandoned
- 2017-04-06 CA CA3019828A patent/CA3019828A1/en active Pending
- 2017-04-06 WO PCT/US2017/026395 patent/WO2017177032A2/en active Application Filing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6877357B2 (ja) | Ｇｄｆ８阻害剤を用いて、強度及び機能を増加させる方法 | |
| JP2020508303A5 (de) | ||
| JP2019536806A5 (de) | ||
| JP2020518599A5 (de) | ||
| JP2019523295A5 (de) | ||
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JP2020500538A5 (de) | ||
| JP2006512899A5 (de) | ||
| JP2017528476A5 (de) | ||
| JP2018535650A5 (de) | ||
| HRP20212028T1 (hr) | Postupci za liječenje hiperlipidemije inhibitorom angptl8 i inhibitorom angptl3 | |
| JP2019513751A5 (de) | ||
| JP2018508462A5 (de) | ||
| JP2011528902A5 (de) | ||
| JP2017113019A5 (de) | ||
| JP2018507220A5 (de) | ||
| JP2015532292A5 (de) | ||
| JP2014511179A5 (de) | ||
| JP2011506483A5 (de) | ||
| JP2015503909A5 (de) | ||
| JP2016094424A5 (de) | ||
| JP2020521797A5 (de) | ||
| AU2019236656A1 (en) | Anti-ccl2 and anti-loxl2 combination therapy for treatment of scleroderma | |
| CN108064169A (zh) | 抗体、用途和方法 | |
| RU2011142183A (ru) | Средство для лечения ревматоидного артрита |